April 29, 2022 — Nano-X Imaging LTD, an innovative medical imaging technology company, today announced that its deep-learning medical imaging analytics subsidiary, Nanox.AI, received FDA 510(k) clearance for HealthOST device, an AI software that provides qualitative and qua
You could feel the energy and excitement at the 2022 HIMSS Global Health Conference & Exhibition (HIMSS22) held this March in Orlando. Just weeks before the conference began, Florida lifted its mask mandate, so it almost felt — dare we say — like pre-COVID days. HIMSS22 did have a health and safety protocol in place, which was developed with due consideration for prevailing public health guidance, legal guidelines and industry practices.
If you enjoy this content, please share it with a colleague
During a Philips international media roundtable at HIMSS22, Mandi Bishop, vice president analyst at Gartner, a technological research and consulting firm, presented the trends and top predictions in healthcare and life sciences for 2022.
April 28, 2022 — Boston Imaging, the United States headquarters of Samsung digital radiography and ultrasound systems, introduces the GM85 Fit, a new configuration of the premium AccE GM85; a digital radiography device featuring a user-centric design that aids in efficient and effective patient care. The GM85 Fit recently received 510(k) clearance from the U.S.
April 28, 2022 — Intelerad Medical Systems, a global leader in medical image management solutions, announced the appointment of two new executives to its leadership team. AJ Watson has been named Chief Product Officer, and Paul Johnson joins as Intelerad’s new Chief Delivery Officer.
April 28, 2022 — Today, the Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), announced new measures that will allow consumers to more easily find the right form of quality, affordable health care coverage on HealthCare.gov that best meets their needs. These measures set the landscape for the upcoming HealthCare.Gov Open Enrollment Period, which will begin on Nov.
April 27, 2022 — Lumea, a global leader in integrated digital pathology solutions and Verily, an Alphabet precision health company, announced a strategic development partnership.
